Pediatric patients with chronic migraine may see reductions in headache frequency and disability with onabotulinumtoxin A.

Premature menopause, usually occurring among women 40 years and younger, is associated with a higher risk for developing hypertension, ...

Any occupational exposure to pesticides is associated with an increased risk for amyotrophic lateral sclerosis.

Poor self-reported sleep quality is associated with larger choroid plexus volume and neurodegeneration in cognitively unimpaired older adults.

The FDA has approved mFlusiva, the first mRNA-based influenza vaccine, for adults aged 50 years and older, with accelerated approval for those 65 and older.

An accelerated pace of biological aging may predict decreased brain volume, cognitive decline, and incident dementia among older adults.

A history of traumatic brain injury may reduce the diagnostic accuracy of blood biomarkers used to detect Alzheimer disease ...

Improving and maintaining optimal midlife vascular health is associated with an increased number of dementia-free survival years.

The FDA has approved Orzeyful (oveporexton), a first-in-class oral orexin receptor 2 agonist, for the treatment of adult narcolepsy type 1.

Obstructive sleep apnea is linked to poorer memory performance and a higher estimated risk for dementia in cognitively unimpaired middle-aged adults.

As autism therapy utilization and spending expand rapidly, federal agencies are pushing for state oversight to manage Medicaid budget policy.

Micro- and nanoplastics are detected more in patients with STEMI than in patients with chronic coronary syndromes or control populations.